semaglutide approved for obesity π£ FDA Approves Wegovy HD (semaglutide 7.2 mg) β the highest-dose GLP-1 RA yet chronic weight management in adults with or overweight + β₯1 weight-related condition. π£ Lightning-fast approval in Obesity | Novo Nordisk U.S.
Pay in 4 interest-free payments of $7.06 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Sep 1 - Sep 6



























